Octagon Capital Advisors LP Centessa Pharmaceuticals PLC Transaction History
Octagon Capital Advisors LP
- $414 Million
- Q3 2024
A detailed history of Octagon Capital Advisors LP transactions in Centessa Pharmaceuticals PLC stock. As of the latest transaction made, Octagon Capital Advisors LP holds 2,012,052 shares of CNTA stock, worth $35.3 Million. This represents 7.77% of its overall portfolio holdings.
Number of Shares
2,012,052
Previous 2,345,075
14.2%
Holding current value
$35.3 Million
Previous $21.2 Million
51.93%
% of portfolio
7.77%
Previous 4.9%
Shares
5 transactions
Others Institutions Holding CNTA
# of Institutions
108Shares Held
118MCall Options Held
5.9KPut Options Held
53K-
Medicxi Ventures Management (Jersey) LTD20MShares$350 Million66.33% of portfolio
-
Index Venture Life Associates Vi LTD St. Helier, Y99.96MShares$175 Million100.0% of portfolio
-
General Atlantic LLC New York, NY9.68MShares$170 Million4.42% of portfolio
-
Perceptive Advisors LLC New York, NY6.28MShares$110 Million2.62% of portfolio
-
First Light Asset Management, LLC Edina, MN5.94MShares$104 Million8.27% of portfolio
About Centessa Pharmaceuticals plc
- Ticker CNTA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 94,339,296
- Market Cap $1.65B
- Description
- Centessa Pharmaceuticals plc, a clinical-stage pharmaceutical company, discovers, develops, and delivers medicines to patients. Its registrational pipeline products include Lixivaptan, a vasopressin V2 receptor small molecule inhibitor that is in Phase III clinical development for the treatment of autosomal dominant polycystic kidney disease; an...